Target intelligence / Profile preview

Dexamethasone-induced protein (DEXI) (DEXI)

Target
DEXI
Molecular classification
Other (not a classical receptor, enzyme, transporter, or transcription factor; classified as a protein of unknown function in many databases)[2][7][8]
01

Overview

Dexamethasone-induced protein (DEXI) is a small, acidic protein of around 10 kDa, encoded by the DEXI gene (Gene ID: 28955, UniProt: O95424), and is upregulated at the transcript level in response to dexamethasone and possibly other glucocorticoids[2][7]. The protein is present in human, mouse, and rat tissues but lacks a well-defined molecular function, classification, or cellular pathway association. Mouse knockout models do not display significant phenotypes and no molecular function or biological process has been verified experimentally[8]. DEXI is associated with serum immunoglobulin A deficiency and other selective immunoglobulin deficiencies, making it of potential interest as an immune function-related marker but not as a classical therapeutic target[7]. Its only disease link is as an association or marker, not a causative or actionable therapeutic target. There is insufficient evidence to classify this as a receptor, enzyme, or other druggable protein[2][6][7][8].

Other names
Dexi homologDEXIMYLEProtein MYLEdexamethasone-induced transcript[2][7][8]
02

Mechanism of action

Not applicable (not a drug target; DEXI is regulated at the transcript level by dexamethasone, not targeted by drugs)[2][6]

03

Biological functions

Possible modulation of inflammatory protein function (putative based on antibody supplier and glucocorticoid association)[2]No experimentally established molecular function or biological process in mouse models[8]
04

Disease associations

Immunoglobulin A deficiency 1[7]Selective immunoglobulin deficiency disease[7]Other (possibly involved in immune function; no strong disease mechanism established)
05

Safety considerations

None established (no therapeutic targeting or drug safety literature for DEXI)[7][8]
06

Interacting drugs

None known (no direct drug interactions reported; dexamethasone regulates its expression but does not directly target the protein itself)[2][6]
07

Biomarkers

Potential marker for glucocorticoid responsiveness[2]

Beyond the preview

Go deeper on Dexamethasone-induced protein (DEXI) (DEXI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dexamethasone-induced protein (DEXI) (DEXI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call